{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:09:24Z","timestamp":1792634964383,"version":"4.5.0"},"reference-count":50,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.1167\/tvst.14.11.38","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:30:37Z","timestamp":1764163837000},"page":"38","source":"Crossref","is-referenced-by-count":2,"title":["The Co-Transduction Conundrum: Improving Dual rAAV Delivery Through Co-Administration of Capsid Serotypes With Complementary Tropism"],"prefix":"10.1167","volume":"14","author":[{"given":"Rachel L.","family":"Fehrman","sequence":"first","affiliation":[{"name":"Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Lipinski","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA"},{"name":"Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"13467","DOI":"10.3390\/ijms232113467","article-title":"Inherited retinal diseases","volume":"23","author":"Ben-Yosef","year":"2022","journal-title":"Int J Mol Sci"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol Ther"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"14500","DOI":"10.1038\/ncomms14500","article-title":"In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1566523221666211006120355","article-title":"CRISPR systems suitable for single AAV vector delivery","volume":"22","author":"Stevanovic","year":"2021","journal-title":"Curr Gene Ther"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4172\/2157-7412.1000311","article-title":"A fragmented adeno-associated viral dual vector strategy for treatment of diseases caused by mutations in large genes leads to expression of hybrid transcripts","volume":"7","author":"McClements","year":"2016","journal-title":"J Genet Syndr Gene Ther"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/emmm.201302948","article-title":"Effective delivery of large genes to the retina by dual AAV vectors","volume":"6","author":"Trapani","year":"2014","journal-title":"EMBO Mol Med"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","article-title":"Triple vectors expand AAV transfer capacity in the retina","volume":"26","author":"Maddalena","year":"2018","journal-title":"Mol Ther"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/gt.2013.3","article-title":"Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus","volume":"20","author":"Lopes","year":"2013","journal-title":"Gene Ther"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fnins.2017.00503","article-title":"Evaluating efficiencies of dual AAV approaches for retinal targeting","volume":"11","author":"Carvalho","year":"2017","journal-title":"Front Neurosci"},{"key":"bib11","first-page":"29","article-title":"Dual vector expansion of the recombinant AAV packaging capacity","volume":"219","author":"Duan","year":"2003","journal-title":"Methods Mol Biol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/75390","article-title":"Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors","volume":"18","author":"Nakai","year":"2000","journal-title":"Nat Biotechnol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/75087","article-title":"Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization","volume":"6","author":"Sun","year":"2000","journal-title":"Nat Med"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/75080","article-title":"A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation","volume":"6","author":"Duan","year":"2000","journal-title":"Nat Med"},{"key":"bib15","first-page":"287","article-title":"Trans-splicing vectors expand the packaging limits of adeno-associated virus for gene therapy applications","volume":"76","author":"Duan","year":"2003","journal-title":"Methods Mol Med"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1093\/hmg\/ddz130","article-title":"Has retinal gene therapy come of age? From bench to bedside and back to bench","volume":"28","author":"Trapani","year":"2019","journal-title":"Hum Mol Genet"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV serotypes and their applications in gene therapy: an overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1148795","DOI":"10.3389\/fddev.2023.1148795","article-title":"AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery","volume":"3","author":"Koponen","year":"2023","journal-title":"Front Drug Deliv"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"20610","DOI":"10.1074\/jbc.M101559200","article-title":"Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer","volume":"276","author":"Walters","year":"2001","journal-title":"J Biol Chem"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"9831","DOI":"10.1128\/JVI.00878-06","article-title":"The 37\/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9","volume":"80","author":"Akache","year":"2006","journal-title":"J Virol"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"13532","DOI":"10.1074\/jbc.M110.210922","article-title":"Terminal N-linked galactose is the primary receptor for adeno-associated virus 9","volume":"286","author":"Shen","year":"2011","journal-title":"J Biol Chem"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1310050","DOI":"10.3389\/fmed.2023.1310050","article-title":"Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studies","volume":"10","author":"Xia","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-4939-7522-8","article-title":"Small and micro-scale recombinant adeno-associated virus production and purification for ocular gene therapy applications","volume":"1715","author":"Reid","year":"2018","journal-title":"Methods Mol Biol"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/hgtb.2014.120","article-title":"Development of a rapid, robust, and universal picogreen-based method to titer adeno-associated vectors","volume":"26","author":"Piedra","year":"2015","journal-title":"Hum Gene Ther Methods"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jgm.1126","article-title":"Novel AAV serotypes for improved ocular gene transfer","volume":"10","author":"Lebherz","year":"2008","journal-title":"J Gene Med"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/hmg\/10.26.3075","article-title":"Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model","volume":"10","author":"Auricchio","year":"2001","journal-title":"Hum Mol Genet"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1089\/104303403322542301","article-title":"Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina","volume":"14","author":"Lotery","year":"2004","journal-title":"Hum Gene Ther"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"a017285","DOI":"10.1101\/cshperspect.a017285","article-title":"The status of RPE65 gene therapy trials: safety and efficacy","volume":"5","author":"Pierce","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"809118","DOI":"10.3389\/fmed.2021.809118","article-title":"Gene therapy advances: a meta-analysis of AAV usage in clinical settings","volume":"8","author":"Au","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41551-022-00934-x","article-title":"Publisher Correction: Efficient in vivo base editing via single adenoassociated viruses with size-optimized genomes encoding compact adenine base editors","volume":"6","author":"Davis","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","article-title":"Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors","volume":"6","author":"Davis","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.9.7.20","article-title":"Assessment of AAV dual vector safety in the Abca4-\/- mouse model of Stargardt disease","volume":"9","author":"McClements","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1089\/hum.2019.132","article-title":"Dual ABCA4-AAV vector treatment reduces pathogenic retinal A2E accumulation in a mouse model of autosomal recessive Stargardt disease","volume":"30","author":"Dyka","year":"2019","journal-title":"Hum Gene Ther"},{"key":"bib34","first-page":"611","article-title":"Adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes","volume":"90","author":"McClements","year":"2017","journal-title":"Yale J Biol Med"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/sj.mt.6300322","article-title":"A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner","volume":"16","author":"Ghosh","year":"2008","journal-title":"Mol Ther"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/hmg\/ddae144","article-title":"Delivering large genes using adeno-associated virus and the CRE-lox DNA recombination system","volume":"33","author":"Datta","year":"2024","journal-title":"Hum Mol Genet"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1006\/mthe.2001.0456","article-title":"Expanding AAV packaging capacity with Trans-splicing or overlapping vectors: a quantitative comparison","volume":"4","author":"Duan","year":"2001","journal-title":"Mol Ther"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/hum.2010.122","article-title":"Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences","volume":"22","author":"Ghosh","year":"2011","journal-title":"Hum Gene Ther"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"110223","DOI":"10.1016\/j.exer.2024.110223","article-title":"The vectors went in two-by-two: transduction efficiency and tolerability of dual and triple rAAV vector delivery following intravitreal injection for genome-editing applications","volume":"251","author":"Fehrman","year":"2025","journal-title":"Exp Eye Res"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3390\/ijms22042096","article-title":"Retinal inflammation, cell death and inherited retinal dystrophies","volume":"22","author":"Olivares-Gonz\u00e1lez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol Ther"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1172\/JCI57367","article-title":"The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice","volume":"121","author":"Bell","year":"2011","journal-title":"J Clin Invest"},{"key":"bib44","first-page":"6089","article-title":"Preclinical safety and efficacy of intein-based dual-AAV gene therapy for Stargardt disease","volume":"65","author":"Favre","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.ymthe.2025.01.042","article-title":"Systematic empirical evaluation of individual base editing targets: Validating therapeutic targets in USH2A and comparison of methods","volume":"33","author":"Tachida","year":"2025","journal-title":"Molecular Therapy"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1016\/j.ymthe.2023.10.017","article-title":"Dual AAV-based PCDH15 gene therapy achieves sustained rescue of visual function in a mouse model of Usher syndrome 1F","volume":"31","author":"Riaz","year":"2023","journal-title":"Mol Ther"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jgm.1126","article-title":"Novel AAV serotypes for improved ocular gene transfer","volume":"10","author":"Lebherz","year":"2008","journal-title":"J Gene Med"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1089\/hum.2020.043","article-title":"Retinal tropism and transduction of adeno-associated virus varies by serotype and route of delivery (intravitreal, subretinal, or suprachoroidal) in rats","volume":"31","author":"Han","year":"2020","journal-title":"Hum Gene Ther"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.survophthal.2024.05.004","article-title":"Biomechanical considerations for optimising subretinal injections","volume":"69","author":"L'Abbate","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.3390\/jcm11164717","article-title":"Subretinal injection techniques for retinal disease: a review","volume":"11","author":"Irigoyen","year":"2022","journal-title":"J Clin Med"},{"key":"bib4","doi-asserted-by":"crossref","DOI":"10.1101\/298620","article-title":"Rational design of a compact CRISPR-Cas9 activator for AAV-mediated delivery","volume-title":"bioRxiv (Preprint)","author":"Vora"},{"key":"bib43","article-title":"SpliceBio announces first patient dosed in phase 1\/2 ASTRA study of SB-007, a dual-AAV gene therapy for Stargardt disease - SpliceBio"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2811152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:30:39Z","timestamp":1764163839000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2811152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.14.11.38","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}